Sentences with phrase «which diabetes patients»

Through ongoing research, he hopes to be able to specifically identify which diabetes patients are at risk of developing advanced liver disease and to develop therapies that protect against disease progression.

Not exact matches

Sanofi, a diabetes specialist which is now facing increased competition from rivals, has been on a mission to boost its treatment pipeline with new products for diseases that affect a wide swath of patients.

Intarcia has completed several late - stage clinical trials in which it uses the pump to deliver a glucose - controlling drug continuously for months — an idea, that if successful (and approved by the FDA) could significantly help patients with type 2 diabetes, fewer than half of whom maintain the recommended glycemic levels.

Omada, which is currently the nation's largest federally - recognized provider of diabetes prevention programs in the U.S., has over 45,000 enrolled patients.

Mannkind, which focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, entered a shallow but persistent downtrend in 2004, posting a series of lower highs into 2015.

Not all strains of the same species were considered «positive responders» to the diet and of the 15 capable strains only five produced butyrate, which may improve insulin sensitivity in type 2 diabetes patients.

Dr David Unwin, Expert Clinical Advisor for Diabetes at the Royal College of General Practitioners and GP at The Norwood Surgery in Southport, discusses why he introduced a low carbohydrate diet for patients with type 2 diabetes — work which saw him named the 2016 NHS Innovator of tDiabetes at the Royal College of General Practitioners and GP at The Norwood Surgery in Southport, discusses why he introduced a low carbohydrate diet for patients with type 2 diabetes — work which saw him named the 2016 NHS Innovator of tdiabetes — work which saw him named the 2016 NHS Innovator of the Year.

She also prescribed metformin, which is a drug patients with diabetes take.

Tear samples from patients with diabetes show elevated levels of substance P, which are related to early damage to the corneal nerves, which may contribute to the development of corneal ulcers and poor wound healing in patients with diabetes, according to the pilot study by Maria Markoulli, PhD, MOptom, FAAO, and colleagues of University of New South Wales, Sydney, Australia.

This imaging approach could also, in the future, help better define which patients with autoimmunity will likely progress to diabetes and classify subgroups of patients who might benefit from different therapeutic strategies.

Piggybacking on traditional diabetes technology, the PDH sends the patient's health information via modem or broadband connection to a central server every night, where InterMed's software analyzes it and produces a personalized feedback report, which is then e-mailed to the patient and care provider.

The study, «AKR1B1 promotes basal - like breast cancer progression by a positive feedback loop that activates the EMT program,» which has been published in The Journal of Experimental Medicine, suggests that an inhibitor of this enzyme currently used to treat diabetes patients could be an effective therapy for this frequently deadly form of cancer.

Rapamycin can make patients susceptible to some opportunistic infections and has been linked to hyperglycemia, which can cause type 2 diabetes, and high levels of triglycerides in the blood, which can contribute to heart disease.

They also discovered that patients feel frustrated over not having access to psychological support; something which patients believe can moderate this diabetes - related stress.

Insulin injections, which form the backbone of treatment for diabetes patients, can be deployed in different ways.

The main treatment is through growth hormone, which is contraindicated in children suffering of diabetes, because the drug increases levels of blood glucose and complicates the health of diabetic patients.

Patients with Type I diabetes lack insulin, which is normally produced by the pancreas and regulates metabolism by stimulating muscle and fat tissue to absorb glucose from the bloodstream.

Between 19 and 34 percent of patients with diabetes develop chronic foot ulcers, the presence of which significantly increases their risk of death compared with patients without foot ulcers.

«Meanwhile, OSA has been shown to be very common in patients with Type 2 diabetes, which is not surprising considering that excess weight contributes to the development of both of these conditions.

Common to all diabetes patients is that they lack the ability to produce sufficient amounts of insulin, which regulates the blood sugar in the body.

More than half of TKR patients have a body mass index (BMI) within the obesity range (greater than 30 kg / m ²), which has been linked to a higher risk for related comorbidities such as diabetes, hypertension, osteoarthritis; and in some studies, to higher medical costs and longer hospital stays.

Doctors at three leading research institutions and the American Diabetes Association report that treating patients with prediabetes as if they had diabetes could help prevent or delay the most severe complications associated with this chronic disease, which affects about thirty million people in the UnitedDiabetes Association report that treating patients with prediabetes as if they had diabetes could help prevent or delay the most severe complications associated with this chronic disease, which affects about thirty million people in the Uniteddiabetes could help prevent or delay the most severe complications associated with this chronic disease, which affects about thirty million people in the United States.

Instead of being insulin resistant, Guevara - Aguirre's patients seem to be especially sensitive to insulin, which may protect them against diabetes.

The authors and editorialist express grave concerns that there will be many needless premature deaths as well as preventable heart attacks and strokes if patients who would clearly benefit from statins are not prescribed the drug, refuse to take the drug, or stop using the drug because of ill - advised adverse publicity about benefits and risks, which may include misplaced concerns about the possible but unproven small risk of diabetes.

The method, which involves inserting genetic material that makes the cells» development run backwards, opens the door to stem cells specific to patients, which could be used to repair damaged organs or fight diseases such as Parkinson's and diabetes — crucially, all without the need to destroy human embryos.

Patients were recruited into two research projects — the DIPP (Finnish Type 1 Diabetes Prediction and Prevention) study in Finland and the international VirDiab (Viruses in Diabetes) study, which included cases and control children from seven European countries.

Reducing the high type 1 diabetes mortality rates will need additional expenditure on the care of patients with the disorder, many of the benefits from which might not be seen for up to 20 years.

In the pilot, 182 patients with Type 2 diabetes received mental health coaching, including an average of three visits in which the coach helped them find tools to best address the stressors and challenges in their lives.

The patients without diabetes produced autoantibodies that completely impaired the activity of a subtype of interferon known as interferon - alpha, which is produced by the immune cells and may cause inflammation.

The leading single cause of CKD is diabetes which is increasing so it's expected that more patients will be diagnosed with CKD in the future.

Dr. Sonjia Kenya, Ed.D. and her colleagues at the University of Miami Miller School of Medicine examined the extent to which Hispanic patients with diabetes understood how to use their glucometers by querying community health workers.

Providers decide upon pharmacological approaches based on numerous factors, the foremost of which is the extent to which the patient's diabetes is controlled.

The artificial pancreas — a device which monitors blood glucose in patients with type 1 diabetes and then automatically adjusts levels of insulin entering the body — is likely to be available by 2018, conclude authors of a paper in Diabetologia (the journal of the European Association for the Study of Didiabetes and then automatically adjusts levels of insulin entering the body — is likely to be available by 2018, conclude authors of a paper in Diabetologia (the journal of the European Association for the Study of DiabetesDiabetes).

The study, «The Potential for Glycemic Control Monitoring and Screening for Diabetes at Dental Visits Using Oral Blood,» builds upon an earlier pilot study in which the feasibility and acceptability to patients and dental providers of using oral blood to screen for diabetes during a routine dental exam was demonDiabetes at Dental Visits Using Oral Blood,» builds upon an earlier pilot study in which the feasibility and acceptability to patients and dental providers of using oral blood to screen for diabetes during a routine dental exam was demondiabetes during a routine dental exam was demonstrated.

Influenza remains a major health problem in the United States, resulting each year in an estimated 36,000 deaths and 200,000 hospitalizations.4 Those who have been shown to be at high risk for the complications of influenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implications.

It has been reported that in a Tg rodent (rat) model expressing hIAPP, diabetes onset coincides with a ∼ 60 % deficit in β cell mass (Butler et al., 2004), which resembles the ∼ 70 % loss of β cell mass observed in patients with T2D (Butler et al., 2003).

Other researchers at Joslin are conducting large scale genetic screening for novel therapeutic targets to control autoimmunity, which will complement the effort of BAIRT to extend autologous beta cell replacement to patients with type 1 diabetes.

Complementing this work are recent advances at Joslin identifying new islet growth in patients with long - standing type 1 diabetes, as well as identifying potential islet growth factors, which occur in situations of insulin resistance, that could be used to stimulate the growth of the patient's own beta cells.

We're trying to track down exactly what these metabolites are, how they might influence insulin sensitivity, and which will be important regulators of blood glucose or weight gain, the two factors we really want to improve in patients at risk for type 2 diabetes.»

Researchers have reported cases in which immunotherapies attacked vital organs, including the colon, liver, lungs, kidney, and pancreas, with some patients experiencing acute, rapid - onset diabetes after receiving the treatments.

It was possible to detect, both in patients with MCI (1.5 % and in patients with dementia (3.5 %, a non-significant difference), abnormal metabolic values, indicating poorly controlled diabetes, renal failure, hyponatremia, folate or vitamin B12 deficiency and hyperthyroidism, which correction led to clinical improvement.

The funding will help support our current clinical trial evaluating the safety and efficacy of ViaCyte's PEC - Direct product candidate, which is in development as a potential cure for patients with high - risk type 1 diabetes.

«While our research started out looking at one particular genetic variant of tribbles, our findings may have a broader impact on patients with type 2 diabetes, because they highlight ways in which elevated levels of tribbles have an effect on the beta cell,» Dr. Kulkarni adds.

Symptoms of diabetes type 1 show up very quickly, usually in a matter of weeks, whereas the symptoms of diabetes type 2 can take years to show up, which can lead to some patients taking a long time to recognize them, worsening the situation.

But suppressing those hormones leads to loss of muscle mass and strength as well as increased body fat, which puts patients at risk for diabetes, heart disease and other health problems, the Ohio State University researchers explained.

Even worse, diabetes has been reported in surprisingly high numbers of patients taking statins — the very condition which propels millions of Americans toward circulatory problems, heart attacks and strokes!

Exenatide and sitagliptin are type 2 diabetes drugs which improve the actions of a gut hormone called GLP - 1 (glucagon - like peptide 1), which is effective for the lowering of blood sugar in type 2 diabetes patients.

Sorbitol is a sugar which accumulates in kidney cells, nerve cells, and cells in the eyes of type 2 diabetes patients.

In the 1970s, Dr. Anderson followed these studies in which he fed patients with type 2 diabetes a low - fat, plant - based, whole - food diet containing sufficient calories to prevent weight loss.

In the study, which was published in the December 2003 issue of Diabetes Care, scientists evaluated 60 patients with type 2 diabetes (30 men and 30 women aged between 44 and 58 years) and divided them into 6Diabetes Care, scientists evaluated 60 patients with type 2 diabetes (30 men and 30 women aged between 44 and 58 years) and divided them into 6diabetes (30 men and 30 women aged between 44 and 58 years) and divided them into 6 groups.